Wenfei Xie, MD
Dermatology · Kansas City, MONPI 1255643490
Payments from drug & device makers
Across 567 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novartis$1K
- Johnson & Johnson$1K
- Lilly USA, LLC$1K
- Sun Pharmaceutical Industries Inc.$666
- Amgen$443
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 172 | $3,242 |
| Novartis | 49 | $1,204 |
| Johnson & Johnson(2 entities) | 55 | $1,118 |
| Lilly USA, LLC | 55 | $1,026 |
| Sun Pharmaceutical Industries Inc. | 26 | $666 |
| Amgen | 25 | $443 |
| E.r. Squibb & Sons, L.L.C. | 27 | $415 |
| Pfizer | 23 | $405 |
| UCB, Inc. | 19 | $398 |
| Regeneron Healthcare Solutions, Inc. | 16 | $369 |
| Galderma Laboratories, L.p. | 12 | $330 |
| Incyte Corporation | 14 | $309 |
| Sanofi | 7 | $223 |
| LEO Pharma Inc. | 9 | $169 |
| Organogenesis Inc. | 7 | $150 |
| Dermavant Sciences, Inc. | 9 | $149 |
| Almirall LLC | 4 | $122 |
| Arcutis Biotherapeutics, Inc. | 5 | $76 |
| Genentech USA, Inc. | 5 | $65 |
| VYNE Pharmaceuticals Inc. | 3 | $53 |
| Biofrontera Inc. | 3 | $51 |
| Journey Medical Corporation | 3 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $45 |
| DUSA Pharmaceuticals, Inc. | 2 | $43 |
| Mayne Pharma Commercial LLC | 3 | $41 |
| Fresenius Kabi USA, LLC | 2 | $38 |
| Organon | 2 | $32 |
| Revance Therapeutics, Inc. | 1 | $27 |
| EPI Health, LLC | 1 | $22 |
| Kerecis Limited | 2 | $20 |
| Mission Pharmacal Company | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $15 |
How this compares
$11,350 in reported general payments places this provider in the 75th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Kansas City
- John RuppKansas City$24K
- Joseph SchneiderKansas City$13K
- Kimberly SchoofsKansas City$13K
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
- Amy MusiekSaint Louis$577K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.